Related Experiment Videos
Arthropathy associated with palmoplantar pustulosis
Clinical Rheumatology
|June 1, 1991
Summary
Palmoplantar pustulosis (PPP) patients frequently experience rheumatic complaints, including chest wall involvement and peripheral arthropathy. A significant association was found with the HLA-B27 antigen.
Area of Science:
- Dermatology
- Rheumatology
- Immunogenetics
Background:
- Palmoplantar pustulosis (PPP) is a chronic inflammatory skin condition.
- Rheumatic complaints are sometimes observed in patients with PPP.
- The genetic associations of PPP, particularly with human leukocyte antigen (HLA) types, require further investigation.
Purpose of the Study:
- To investigate the prevalence of rheumatic complaints in patients diagnosed with palmoplantar pustulosis.
- To identify potential associations between PPP and specific HLA antigens.
Main Methods:
- A survey of 170 patients with palmoplantar pustulosis was conducted.
- Data collected included family history, dermatological and rheumatological examinations, and radiography for suspected joint involvement.
- Screening for active chest-wall symptoms using scintigraphy and HLA antigen typing were performed.
Main Results:
- Twenty-five patients (14.7%) reported rheumatic complaints, with anterior chest-wall involvement (15 patients), sacroiliitis (6 patients), and peripheral arthropathy (11 patients) being common.
- A high incidence of the HLA-B27 antigen was documented in 32% of patients, a finding similar to that observed in psoriatic arthritis.
- No significant association was found with other HLA antigens commonly associated with psoriasis (HLA-B13, -17, -37, CW6).
Conclusions:
- Rheumatic conditions, particularly anterior chest-wall involvement and arthropathy, are common in patients with palmoplantar pustulosis.
- The strong association with HLA-B27 suggests a potential shared immunogenetic pathway between PPP and spondyloarthropathies.
- Further research is warranted to elucidate the relationship between PPP, rheumatic diseases, and specific genetic markers.